Filing Details

Accession Number:
0001213900-14-008549
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-24 14:55:48
Reporting Period:
2014-11-14
Filing Date:
2014-11-24
Accepted Time:
2014-11-24 14:55:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438533 Retrophin Inc. RTRX Pharmaceutical Preparations (2834) 262383102
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1525354 Martin Shkreli 101 Avenue Of The Americas, 9Th Floor
New York NY 10013
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-11-14 100,000 $10.23 2,837,168 No 4 S Direct
Common Stock Disposition 2014-11-17 100,000 $9.41 2,737,168 No 4 S Direct
Common Stock Disposition 2014-11-18 254,975 $9.19 2,482,193 No 4 S Direct
Common Stock Disposition 2014-11-19 329,824 $8.54 2,152,369 No 4 S Direct
Common Stock Disposition 2014-11-20 134,354 $8.23 2,018,015 No 4 S Direct
Common Stock Disposition 2014-11-21 252,847 $8.41 1,765,168 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Prepaid Forward Contract (obligation to sell) Acquisiton 2014-09-09 123,000 $0.00 123,000 $0.00
Common Stock Prepaid Forward Contract (obligation to sell) Acquisiton 2014-09-12 205,000 $0.00 205,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
123,000 2016-09-12 2016-09-14 Yes 4 J Direct
205,000 2016-09-15 2016-09-21 Yes 4 J Direct
Footnotes
  1. On September 9, 2014, the reporting person entered into a prepaid forward contract with an unaffiliated third party buyer. The contract obligates the reporting person to deliver to the buyer, at the reporting person's option, up to 123,000 shares of common stock, par value $0.0001 per share ("Common Stock"), of Retrophin, Inc., cash or a combination thereof on the maturity date of the contract (September 14, 2016). In exchange for assuming this obligation, the reporting person received a cash payment of $1,069,166 as of the date of entering into the contract. The reporting person pledged 123,000 shares of Common Stock (the "September 9 Pledged Shares") to secure his obligations under such contract and retained voting rights in the September 9 Pledged Shares during the term of the pledge.
  2. On September 12, 2014, the reporting person entered into a prepaid forward contract with an unaffiliated third party buyer. The contract obligates the reporting person to deliver to the buyer, at the reporting person's option, up to 205,000 shares of Common Stock, cash or a combination thereof on the maturity date of the contract (September 21, 2016). In exchange for assuming this obligation, the reporting person received a cash payment of $1,789,679 as of the date of entering into the contract. The reporting person pledged 205,000 shares of Common Stock (the "September 12 Pledged Shares") to secure his obligations under such contract and retained voting rights in the September 12 Pledged Shares during the term of the pledge.